1. Muramatsu, I., Ohmura, T., Kigoshi, S., Hashimoto, S., and Oshita, M. (1990): Pharmacological subclassification of α1,-adrenoceptors in vascular smooth muscle, Br. J. Pharmacol., 99, 197–201.
2. Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo, R.R., Jr., and Trendelenburg, U. (1994): IV. International union of pharmacology nomenclature of adrenoceptors, Pharmacol. Rev., 46, 121–136.
3. Forray, C, Bard, J.A., Wetzel, J.M., Chiu, G., Shapiro, E., Tang, R., Lepor, H., Hartig, P.R., Weinshank, R.L., Branchek, T.A., and Gluchowski, C. (1994): The α1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human α1C subtype, Mol. Pharmacol., 45, 703–708.
4. Hieble, J.P., Bylund, D.B., Clarke, D.E., Eikenburg. DC, Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., and Ruffolo, R.R. (1995): International union of pharmacology X. recommendation for nomenclature of α1-adrenoreceptors: consensus update, Pharmacol. Rev., 47, 267–270.
5. Kuo, G.H., Prouty, C., Murray, W.V., Pulito, V., Jolliffe, L., Cheung, P., Varga, S., Evangelisto. M., and Shaw, C. (2000): Design, synthesis and biological evaluation of pyridine-phenylpiperazines: a novel series of potent and selective α1a-adrenergic receptor antagonist, Bioorg. & Med. Chem., 2263–2275.